INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines – ADMA

Pomerantz LLP has filed class action lawsuits against ADMA Biologics, GeneDx Holdings, and Helen of Troy Limited, alleging securities fraud and unlawful business practices. The lawsuit against ADMA was triggered by a Culper Research report alleging channel stuffing schemes, which caused the stock to fall 16.63% on March 24, 2026, followed by a 13.91% decline after a Cantor Fitzgerald downgrade on March 26, 2026. Investors have until August 10, 2026, to request Lead Plaintiff status.